Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study.
- DOI
- 10.2147/copd.s562498
- Published
- 2026
- Container
- International journal of chronic obstructive pulmonary disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.2147/copd.s562498,
title = {Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study.},
author = {Adrish M and DeMartino JK and Carstens D and Jackson M and Wilson K and Schinkel J and Tkacz J},
year = {2026},
journal = {International journal of chronic obstructive pulmonary disease},
doi = {10.2147/copd.s562498},
url = {https://doi.org/10.2147/copd.s562498}
}RIS
TY - JOUR TI - Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study. AU - Adrish M AU - DeMartino JK AU - Carstens D AU - Jackson M AU - Wilson K AU - Schinkel J AU - Tkacz J PY - 2026 JO - International journal of chronic obstructive pulmonary disease DO - 10.2147/copd.s562498 UR - https://doi.org/10.2147/copd.s562498 ER -
APA
M, A., JK, D., D, C., M, J., K, W., J, S., & J, T. (2026). Effectiveness of Benralizumab in Reducing Asthma and COPD Exacerbations in Patients with Severe Asthma and Concomitant COPD: Real-World Evidence from the ZEPHYR-5 Study.. International journal of chronic obstructive pulmonary disease. https://doi.org/10.2147/copd.s562498
Source records
- pubmed · retrieved 2026-09-27T14:26:19.378Z